Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of cost gouging, declaring the stark distinction concerning U.S. charges and those in Europe and copyright. Incorporate these bits and parts into